1,4-substituted piperazine derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 24, 2012
Grant Date -
Mar 5, 2009
app pub date -
Apr 5, 2006
filing date -
Apr 6, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A compound represented by the formula (I):This compound has a metabotropic glutamate receptor 1 inhibitory effect, and therefore is useful for the treatment of a brain disorder such as convulsion, acute pain, inflammatory pain, chronic pain, cerebral infraction or transient cerebral ischemic attack, a mental dysfunction such as schizophrenia, and a disease such as anxiety and drug addition.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully